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Characterization of the Han:SPRD rat model for hereditary polycystic
kidney disease. The Han:SPRD rat model for inherited polycystic
kidney disease (PKD) was characterized (clinical parameters, morphol-
ogy, immunohistochemistry and in situ hybridization). Homozygous
animals died of uremia after three to four weeks with severe cystic
transformation of virtually all nephrons and collecting ducts (serum
urea: 616 195 mgldl; kidney-to-body weight ratio: > 20%). In
heterozygotes, slow progression of the disease led to death between the
12th and 21st month (median: 17 months; serum urea levels above 200
mg/dl). Kidney enlargement was moderate, and cysts were restricted to
the cortex and outer medulla. Immunohistochemical markers showed
that approximately 75% of the cysts were derived from the proximal
tubule. Cystic transformation started in the proximal tubule with a
sharp onset of basement membrane alteration and a loss of epithelial
differentiation restricted to small focal areas. In these areas, al(IV)
collagen and laminin 131 mRNA were enhanced as revealed by isotopic
and non-isotopic in situ hybridization. Fibroblasts underlying the af-
fected tubular portions were involved in matrix overexpression result-
ing in subepithelial accumulation of immunoreactive collagen IV and
laminin. In later stages of cystic transformation distal nephron segments
were affected as well. A reversal in epithelial polarity as judged from
Na,K-ATPase-immunoreactivity was not observed. Renal immunore-
active renin-status was significantly decreased. Hematocrit was low-
ered in heterozygotes (40.4 5.8 vol% compared to 46.7 1.99 vol%
in controls; P < 0.05) and total renal EPO mRNA was reduced to 36
14% of the mean value of control animals, whereas serum EPO levels
were not significantly altered. We conclude that the Han:SPRD rat is a
useful model for the study of human ADPKD since both diseases are
similar in several aspects. The model is particularly suitable for the
study of epithelial-mesenchymal interactions at the beginning of tubular
cystic transformation.
Polycystic kidney disease (PKD) is one of the most frequent
disorders among hereditary renal diseases in humans and ap-
proximately 10% of long-term hemodialysis patients are af-
fected with the disease [1]. Hereditary PKD is transmitted
either as an autosomal dominant (ADPKD) or an autosomal
recessive trait (ARPKD) [1, 2]. While ARPKD mainly affects
distal portions of the renal tubule and leads to death in early
childhood, ADPKD involves all nephron segments [2, 3]. Due
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to slow progression of the disease, ADPKD patients manifest
renal failure not requiring dialysis until the 5th to 6th decade of
life [4]. One major gene defect accounting for approximately
90% of ADPKD has been mapped to the alpha globin gene locus
on the short arm of chromosome 16 [5].
Three major factors have been identified as critical compo-
nents in the pathogenesis of PKD [6]. First, there is accumu-
lating experimental evidence for cell proliferation leading to
cyst expansion [7—10]. Second, extensive changes occurring in
the tubular basement membrane and extracellular matrix sur-
rounding the cysts may play primary or secondary roles in
cystogenesis [11—141. An abnormal connective tissue compo-
nent may not only affect renal tissue, but also induce hepatic
cysts, intestinal diverticula and intracranial aneurysms, indicat-
ing a systemic disorder [6, 12]. Third, late-stage cysts that may
be obstructed or have dislodged from their parent nephrons
contain fluid probably derived from tubular secretion. In this
respect, an eventual reversal of epithelial transport polarity was
discussed based on the detection of mislocated Na,K-ATPase
immunoreactivity in human and experimental ADPKD [15, 16].
ADPKD is often associated with hypertension that may be
caused by an activation of the intrarenal renin-angiotensin
system [17—19]. Hyperactivity of the latter may be due to
compression of renal vessels by enlarging cysts. With respect to
the dysregulation of cystic epithelial growth, an altered tubular
sensitivity for angiotensin II, which acts as a growth factor in
many cell systems, has recently been suspected to cause
hyperplasia of the cyst-lining epithelia [201.
Regarding the close relationship between renal insuffiency
and anemia, in patients with renal insuffiency based on PKD it
was shown that anemia was rather moderate compared to other
causes leading to end-stage renal failure [21—23]. Perstubular
fibroblasts of the cortical labyrinth have recently been identified
as the site of renal erythropoietin production [24], and a
correlation between proximal tubular transport and oxygen
sensing has been suggested [25]. Since elevated erythropoietin
levels were found in proximal cysts [21], the study of EPO
synthesis in PKD may shed light on the mechanism of renal
oxygen sensing.
Several animal models have so far provided insights into the
pathogenic mechanisms underlying renal cyst formation [26,
271. These include several mouse strains in which the disease is
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transmitted in the ARPKD pattern. A first rat strain (Han:
SPRD) suitable for the study of PKD was described by Kaspa-
reit-Rittinghausen, Deerberg and Wcislo in 1989 [28]. This
model is derived from a spontaneous mutation in the Sprague-
Dawley strain and inherits the disease in an autosomal domi-
nant fashion. Heterozygous animals of this strain display slowly
progressive renal cystic disease, whereas homozygous rats
develop massive renal enlargement leading to early death
[28—30]. Previous studies have demonstrated marked epithelial
alterations associated with basement membrane thickening and
loss of cellular differentiation [29, 30].
The objective of this study was to analyze the Han:SPRD rat
model for PKD in more detail with particular emphasis on the
morphology of tubular and interstitial changes. Immunohisto-
chemical techniques were applied to define the origin of the
cysts and to establish changes in Na,K-ATPase localization.
The nature of matrix deposits was analyzed both at the protein
and gene expression level. High resolution in situ hybridization
was applied to identify the cellular sources of pericystic matrix
accumulations. To detect potential abnormalities in renin syn-
thesis, the distribution of renin-containing cells was assessed.
Erythropoietin production was examined at the protein and
gene expression level. Our findings indicate that the Han:SPRD
rat is an appropriate model for the pathogenesis of PKD in
several respects. In particular, this model is highly suitable to
study initial processes in tubular cystic transformation.
Methods
Animals and clinical parameters
Rats from the Han:SPRD strain exhibiting PKD were origi-
nally obtained from Dr. Deerberg (Central Institute for Labo-
ratory Animal Breeding, Hannover, Germany) and were used
for the development of a breeding colony, which was main-
tained in the laboratory animal facility under control of Dr.
Gretz (Nephrology Section, Mannheim, University of Heidel-
berg) [27, 28]. Homozygous rats (Han:SPRD cy+/cy+) of both
sexes were easily checked for renal cysts by abdominal palpa-
tion due to massively enlarged kidneys. Heterozygous rats
(Han:SPRD cy+/cy—) of either sex at an age over two months
could also be easily distinguished from unaffected littermates by
palpation of the enlarged kidneys and by elevated serum urea
levels (> 60 mgldl in heterozygous animals aged 3 months or
more [27]). Heterozygously unaffected, age-matched litter-
mates (Han:SPRD cy—/cy—) were used as controls. Rats had
free access to tap water and standard rat chow containing 19%
protein.
For the evaluation of clinical parameters, a total of 70
homozygous and 170 heterozygous animals of both sexes,
respectively, and 140 age-matched, heterozygously unaffected
littermates of the corresponding gender were examined. Blood
samples (2 ml) were taken from the retroorbital vein in 14 day
intervals (under light ether anesthesia). Serum probes of 4-
week-old homozygous animals were analyzed for urea and
creatinine levels using a colorimetric method (Hitachi Autoan-
alyzer). For the longitudinal assessment of the development of
uremia in the heterozygotes, serum samples from rats aged 1, 4,
8, 12 and 16 months were analyzed accordingly. Specimens of
24 hour urine from heterozygous animals were checked for
protein excretion (Coomassie brilliant blue staining method).
Blood pressure was measured in 14 day intervals by tail
plethysmography under light ether anesthesia using the tail cuff
method. Animals had been trained for this procedure before the
measurements. Total kidney weight was expressed as a per-
centage of body weight (total kidney-to-body wt ratio). For the
determination of hematocrit, serum erythropoietin (EPO) and
renal EPO messenger (m)RNA levels, six male heterozygotes
and six male control littermates at an age of 9 to 12 months were
used. For evaluation, animals were ether-anesthetized, the
abdominal cavity was opened and the animals were bled via the
abdominal aorta. Blood was taken for the determination of
hematocrit (microcentrifugation) and serum EPO concentra-
tions. Serum samples were stored at —20°C until evaluation by
radioimmunoassay. Both kidneys were rapidly removed. After
determination of the wet weight of single kidneys, tissue was
snap-frozen in liquid nitrogen and stored at —70°C until RNA
was prepared.
For morphological and histochemical analysis, 4 male ho-
mozygous rats at an age of 4 weeks, 10 male heterozygous rats
at an age of 2 months and another 16 male heterozygous rats at
an age of 12 months were investigated. Unaffected age-matched
littermates in equal numbers were used as controls.
Tissue preparation for morphology and histochemistry
To obtain tissue for histology, ultrastructural morphology,
immunohistochemistry and in situ hybridization, animals were
anesthetized by intraperitoneal injection of nembutal (40 mg/kg
body wt) and perfusion-fixed by cannulation of the abdominal
aorta. Animals were perfused for two minutes at a pressure of
220 mm Hg with 3% paraformaldehyde in phosphate buffered
saline (PBS), pH 7.4. The total osmolality of the fixative was
800 mOsm/kg H2O. After perfusion, one kidney was clamped
and removed. Slices of this kidney were either routinely pro-
cessed for paraffin embedding, or postfixed in 1.5% glutaralde-
hyde and then processed for Epon embedding. The remaining
kidney was rinsed for five minutes in PBS adapted to the
osmolality of the fixative by addition of sucrose. Slices of this
kidney were then snap-frozen in liquid nitrogen.
Morphology
Conventional paraffin histology was performed according to
standard techniques. Sections were stained with either hema-
toxylin-eosin (H&E) or periodic-acid Schiff's reaction (PAS).
For fine-structural morphology using light and electron micros-
copy, semithin sections (1 m) were cut and stained in Rich-
ardson's solution. Ultrathin sections were contrasted in uranyl
acetate and lead citrate and examined with a Philips 301
electron microscope at 80 kV. For scanning electron micros-
copy, perfusion-fixed kidney tissue was rinsed in PBS (400
mOsm/kg H20, pH 7.4). Slices of tissue were postfixed for two
hours in 1.5% osmium tetroxide, washed in PBS and dehy-
drated in a series of graded alcohols. Subsequently, the tissue
was dried using liquid carbon dioxide and sputter-coated with
gold. Sections were viewed in a Philipscan 500 scanning elec-
tron microscope at 25 kV.
Immunohistochemistry
For antibody incubation, paraffin sections (5 m) were
mounted on chrome alum-gelatine coated or poly-L-lysine
coated glass slides. Slides were dried at 37 °C for 24 hours and
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then deparaffinized in a series of graded alcohols. The following
antibodies were used: monoclonal mouse anti-human neutral
endopeptidase (NEP) antibody as a marker of the proximal
straight tubule [31] (gift from P. Ronco, Paris, France) at
dilutions of 1:100 and 1:200 in PBS/1% BSA, polyclonal rabbit
anti-rat Tamm Horsfall protein (THP) antibody as a marker of
the distal straight tubule [32] (gift from J. Hoyer, Philadelphia,
Pennsylvania, USA) at dilutions of 1:100 and 1:200 in PBSII%
BSA, polyclonal rabbit anti-mouse NaK-ATPase antibody (al-
subunit; Upstate Biotechnology, Lake Placid, New York,
USA) at a dilution of 1:200 in PBSII% BSA, polyclonal rabbit
anti-mouse collagen IV antibody at dilutions of 1:50 and 1:100 in
PBS/l% BSA (Collaborative Research, Arlington, Virginia,
USA; [33]), polyclonal rabbit anti-mouse laminin antibody
(ImmunoBiologicals, Costa Mesa, California, USA; [33]) at a
dilution of 1:100 in PBS/1% BSA, and polyclonal rabbit anti-rat
renin antibody (gift from E. Hackenthal, Heidelberg, Germany)
at a dilution of 1:5000 in PBS/1% BSA. Detection of the bound
antibody was performed either using a biotinylated second
antibody and streptavidin-Texas red (Amersham Buchler,
Braunschweig, Germany) according to the producer's instruc-
tions, or using the peroxidase-antiperoxidase method (PAP
method; Dakopatts, Glostrup, Denmark). For the latter proto-
col—subsequent to antibody incubation—sections were ex-
posed to 0.1% diaminobenzidine and 0.02% H202 as a source of
the peroxidase substrate. Control experiments were made omit-
ting the first antibody and using 1% BSA instead. Slides were
examined with a Reichert Polyvar microscope equipped for
epifluorescence illumination. Interference contrast optics were
applied for additional morphological information.
In situ hybridization
Messenger RNA expression for collagen IV, laminin and
renin was investigated by in situ hybridization using both
radioactively labeled and non-isotopic riboprobes made from
the respective cDNA's. Five pm-thick cryostat sections were
mounted on poly-L-lysine coated glass slides. Sections were
post-fixed for 30 minutes in 4% paraformaldehyde in PBS (pH
7.4) and stored in 70% ethanol at 4°C until further use.
To generate hybridization probes for al(IV) collagen, a 1139
bp Kpnh/XhoI fragment (from position 491 to 1630) of the
original collagen IV probe [34] was subcloned into the Sal!!
KpnI sites of the pBlueScript IISK vector (Stratagene, La Jolla,
California, USA) to generate antisense RNA probe using a T3
promotor site, and to generate sense RNA probe using a T7
promotor site. The plasmid containing the cDNA fragment was
linearized using either KpnI or Hindu! to generate appropriate
templates for the in vitro transcription of collagen IV antisense
or sense RNA, respectively. In vitro transcription was carried
out using either T3 polymerase (Promega; 1 U/1.d to generate
cRNA) or T7 polymerase (Promega; 1 U4L1 to generate nIRNA)
at 37°C for 90 minutes as described [35].
To generate probes for laminin B 1, a 1094 bp Saci/Hindlil
fragment (from position 4031 to 5125; [36, 37]) was subcloned
into the Saci/Hindlil sites of the pBluescript IISK vector to
generate antisense probe using a T3 promotor site, and to
generate sense RNA using a T7 promotor site. The plasmid
containing the cDNA fragment was linearized using either Sad
or Hindill to generate appropriate templates for in vitro tran-
scription of laminin antisense or sense RNA, respectively.
To generate a hybridization probe for renin, a 330 bp Sac!!
PstI fragment of the mouse Ren-2d cDNA was subcloned into
the pSP65 transcription vector to generate antisense RNA, and
into the pSP64 vector to generate sense RNA [35]. The plasmids
were linearized using Acci for the pSP65 plasmid or KpnI for
the pSP64 plasmid. In vitro transcription was carried out using
SP6 polymerase (Promega; 1 U/pA to generate cRNA and
mRNA, respectively) at 37°C for 90 minutes.
For the generation of radioactively labeled probes, 35S-
labeled UTP (Dupont NEN) was used. For the generation of
digoxigenin-labeled probes, incorporation of digoxigenin-la-
beled UTP was carried out by in vitro transcription using a
non-radioactive nucleic acid detection kit (Boehringer, Mann-
heim, Germany). To obtain randomly shortened fragments of
the labeled probe, time-controlled alkaline hydrolysis was per-
formed according to standard methodology. The hybridization
procedure including the washing steps with both radioactively
labeled and non-isotopic riboprobes was essentially as de-
scribed [24, 32, 351. Washing was carried out at 53°C for 3.5
hours with a final high stringency wash in 0.1 x standard saline
citrate (S SC) containing 50% formamide. After brief washes in
0.5 x SSC and 0.2 x SSC containing formamide, sections were
processed for detection. Radiolabeled sections were dipped in a
1:1 aqueous solution of NTB-2 emulsion (Eastman Kodak,
Rochester, New York, USA) at 45°C, exposed at 4°C in bakelite
boxes containing desiccant, developed with D19 developer
(Kodak) and fixed with Unifix (Kodak). Duration of autoradio-
graphic exposure was either 5, 15 or 30 days for the collagen IV
and renin probes, and 15, 30 or 50 days for the laminin probes,
respectively. Sections were counterstained with H&E, cover-
slipped with phosphate buffered glycerol and photographed
using a Reichert Polyvar microscope. Sections from non-isoto-
pic hybridization were incubated with alkaline phosphatase-
conjugated anti-digoxigenin antibody (dilution 1:5000) at 4°C
overnight. Subsequent color development was performed ac-
cording to the producer's instructions with a developing time of
4 to 48 hours. Slides were coverslipped with 50% glycerol in
PBS and examined in a Reichert Polyvar microscope using
interference contrast optics.
Quantflcation of renin immunostaining
Sections from homozygous, heterozygous and unaffected
Han:SPRD rats were stained for renin with the immunoperox-
idase technique (PAP method) as described above. Renin-
containing portions of the afferent arteriole that were closely
associated with the vascular pole of a glomerulus were attrib-
uted to the juxtaglomerular apparatus (JGA), while renin-
positive cells without connection to a glomerulus were catego-
rized separately. For quantification of the renin status, the total
number of glomeruli as well as the number of glomeruli with an
adherent renin-immunoreactive vascular pole were counted and
the percentage of positive glomeruli was determined (juxtaglo-
merular index); the values obtained correspond to the amount
of renin stored in the afferent arteriolar wall [38]. The number of
arterioles without neighboring glomeruli exhibiting renin-posi-
tive cells was also recorded. Values are given as the mean
number of arterioles per section. Slides were examined by two
observers. A total of 36 sections obtained from 12 different
animals was examined (N = 6 per group).
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Age, 4 weeks
Fig. 1. Serum creatinine (A) and serum urea levels (B, C) in Han:SPRD rats of both sexes. Values are means SD. Symbols are: (U) controls;
(Ii) heterozygous animals; () homozygous animals; * significant difference between heterozygously affected and controls (P < 0.05). Numbers
of animals (cy—/cy—, cy+/cy—, cy+/cy+) represented are: 4-week-old (30, 35, 70), 4-month-old (30, 35), 8-month-old (28, 35), 12-month-old (28,
33), 16-month-old (26, 33).
Determination of EPO mRNA
Total RNA was prepared from left kidneys using an acid-
guanidinium thiocyanate-phenol-chloroform extraction method
[39]. EPO mRNA was measured by ribonuclease (RNAase)
protection as previously described [40]. An RNA probe was
continuously labeled from a genomic rat EPO DNA template
(PstI/SacI fragment containing 132 bp of exon V and approxi-
mately 300 bp of the adjoining intron; kindly provided by Dr. P.
Ratcliffe, Oxford, UK) using SP6 polymerase and alpha 32P-
GTP (410 Cilmmol, Amersham, UK). RNA samples (50 d)
containing 230 jzg total RNA were hybridized with 0.5 x 106
cpm of radiolabeled probe in 80% formamide, 40 mrsi PIPES
(pH 6.4), 400 m NaCl, 1 mtvt EDTA at 60°C overnight and
RNAase digestion was performed at 20°C for 30 minutes. An
equivalent amount of yeast transfer RNA was run to assess
background activity. Protected fragments were subjected to
denaturing PAGE and quantified by measuring radioactivity of
excised portions of the dried gel in liquid scintillant (1500
tri-Carb liquid scintillation analyzer, Packard Instruments Com-
pany, Downers Grove, Illinois, USA). The number of counts
per minute obtained from each EPO mRNA sample was divided
by the quantity of total RNA analyzed for that sample to yield
the quantity of EPO mRNA per jzg of total RNA. Five micro-
grams of an external standard consisting of pooled RNA ex-
tracted from severely hypoxic rats was run with the assay and
assigned an arbitrary value of 1.0.
Determination of serum EPO levels
Serum EPO concentrations were determined by radioimmu-
noassay (RIA) as described [41], with the use of a rabbit
antiserum raised against pure recombinant human EPO and
iodinated human EPO ('251-EPO; Amersham International) as
tracer. A rat serum pool enriched in EPO prepared by exposing
donor animals to hypoxia was used as a standard after calibra-
tion against the Second International Reference Preparation by
in vivo bioassay [41, 42].
Statistical analysis
Values are presented as means standard deviation (SD).
Data were statistically analyzed by the unpaired t-test when two
groups were compared. When three groups were compared,
data were tested by ANOVA followed by pairwise t-tests, and
the level of significance was adjusted by the Bonferroni proce-
dure. Differences of a level of P < 0.05 were considered
significant.
Results
Clinical parameters and renal enlargement
Homozygously affected Han:SPRD rats of both sexes died of
uremia within the first postnatal month (N = 70). In 4-week-old
animals, serum creatinine levels were 2.4 1.1 mgldl (mean
values sD; normal range in Sprague-Dawley rats: 0.5 to 0.6
mg/dl) and serum urea was 616 195 mg!dl (normal range: 15 to
28 mgldl; Fig. 1). Kidneys were massively enlarged by four
weeks of age (mean total kidney weight: 8.6 1.3 g). Thus, the
total kidney-to-body weight ratio was greater than 20% com-
pared to approximately 1% in control animals.
Heterozygously affected Han:SPRD rats of both sexes (N =
170) displayed a slowly progressive form of the disease, since
none of the rats died within the first year of life. In the second
year, the rate of survival of male rats was rapidly declining, as
50% of the animals died between the 12th and 21st month of age
(X = 17 months). Female animals did not die of uremia [27].
During the first year of life, serum creatinine values ranged
between 0.76 to 1.05 mg/dl (Fig. la) and serum urea levels
ranged from 68 to 100 mgldl (Fig. 1 b, c). Significant differences
(P < 0.05) between the heterozygotes and the controls concern-
ing both serum creatinine and serum urea values did not occur
until the eighth month of age (Fig. 1). In later stages of the
disease, azotemia became more severe; in 16-month-old het-
erozygotes, serum creatinine was 1.42 0.36 mgldl (Fig. la)
and serum urea was 132 36 mgldl (Fig. Ic). A significant rise
in blood pressure was not encountered during the whole course
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of the disease. During the first year of life, mean systolic blood
pressure was ranging between 129 to 135 mm Hg in the
heterozygotes compared with 125 to 134 mm Hg in the controls
(Fig. 2a). In 16-month-old heterozygously affected animals,
mean systolic blood pressure was moderately, yet not signifi-
cantly elevated with a mean of 145 7.5 mm Hg as compared
to 136 4 mm Hg in controls (Fig. 2a). A significant proteinuria
was first observed in 8-month-old heterozygous animals (25 7
mg124 hour compared to 10 3 mg124 hour in controls; P <
0.001). Proteinuria was rapidly progressive through the later
course of the disease reaching 96 31 mg!24 hour in 16-
month-old heterozygotes compared to 11 6 mg124 hour in
controls (P < 0.001). Kidney weight at eight weeks of age was
doubled as compared to age-matched controls (3.3 0.4 g in
heterozygotes and 1.4 0.1 g in controls, P < 0.001) resulting
in a total kidney-to-body weight ratio of 1.2%. In 12-month-old
heterozygous animals, the total kidney-to-body weight ratio
was 3.3%.
To assess hematocrit, serum erythropoietin (EPO) level and
renal EPO mRNA content, 6 heterozygously affected rats aged
9 to 12 months were evaluated (Table 1, Fig. 3). Hematocrit
levels were 40.4 5.76 vol% in the heterozygotes and 46.7
1.99 vol% in the controls. Serum EPO concentrations were 22.8
6.7 mU/ml in the diseased and 27.7 4.5 mU/mi in the
controls. These differences were not statistically significant.
Despite the large difference in kidney weight between diseased
and control animals, the yield of total RNA extractable per
kidney was similar (3.29 0.11 arbitrary units in the diseased
and 3.1 0.61 arbitrary units in the controls). The total kidney
EPO mRNA, as determined by RNAase protection (Fig. 3),
revealed that the levels of EPO mRNA per renal mass were
significantly decreased in heterozygous animals (0.10 0.06
arbitrary units/g) as compared to unaffected controls (0.64
0.26 arbitrary units/g; P 0.001). Total kidney EPO mRNA
was 0.29 0.11 arbitrary units in the heterozygotes and 0.70
0.36 arbitrary units in the control animals (P < 0.01).
Renal microanatomy
In the homozygotes, the cystic dilation involved all segments
of the nephron and the collecting duct system with exception of
the glomerulus (Fig. 4 a, b). Cystic enlargement began directly
at the onset of the proximal tubule at the urinary pole of the
glomerulus (Fig. 4b). At four weeks of age, almost the entire
kidney consisted of large cysts, and only a very small propor-
tion of tubules had retained a normal microanatomical aspect.
Fig. 2. Systolic blood pressure (A) and
urinary protein excretion (B) in heterozygous
Han:SPRD rats of both sexes. Values are
means SD. Symbols are: (U) controls; (121)
heterozygous animals; * significant difference
between heterozygously affected and controls
(P < 0.05). Numbers of animals (cy—/cy—,
cy+/cy—) represented are: 4-month-old [30,
35], 8-month-old (28, 35), 12-month-old [28,
33], 16-month-old (26, 33).
Table 1. Hematocrit, serum EPO concentrations and renal EPO
mRNA levels in heterozygous Han:SPRD rats and unaffected control
rats
Total Total
Total kidney
renal EPO
kidney
EPO
RNA mRNA mRNA/g
Serum EPO Weight renal tissue
Hct concentration of renal arbitrary arbitrary
vol% mU/mi tissue g units units/g
Han:SPRD
1 37.1 29 6 2.73 0.206 0.0343
2 33.2 18 10 4.64 0.119 0.0119
3 46.8 33 2.4 2.85 0.338 0.1409
4 43.5 17 3.7 3.50 0.345 0.0932
5 34.4 18 2.4 2.82 0.417 0.1739
6 47.4 22 2.3 3.22 0.291 0.1267
Mean 40.4a 22.8 447a 3.29 0.29a o.loa
SD 5.76 6.7 3.06 0.72 0.11 0.06
Control
1 49.1 25 1.3 3.43 0.676 0.5204
2 45.3 20 1,2 3.62 0.919 0.7655
3 44.1 31 1.1 2.67 0.529 0.4805
4 47.4 30 1.3 3.25 0.683 0.5255
5 49.7 28 1.1 2.04 0.475 0.4315
6 44.7 32 1.3 3.53 1.441 1.1088
Mean 46.7 27.7 1.22 3.1 0.79 0.64
SD 1.99 4.5 0.10 0.61 0.36 0.26
Quantification of EPO mRNA was performed by counting of the
radioactivity of the protected fragments in the gel shown in Figure 3.
Data are related to the counts of protected fragments of an external
standard that was coanalyzed and assigned an arbitrary value of 1, and
yield of total RNA per gram wet weight of tissue was used to calculate
the total amount of EPO mRNA. Abbreviation Hct is hematocrit.
a Significant difference between heterozygously affected and controls
(P < 0.05)
In the inner medulla, cystic changes were less prominent. Most
of the renal tubules were lined by a fiat, simplified epithelium
and only a few cyst epithelia still displayed morphological
features of their original nephron segment. The tubular base-
ment membrane was normal-sized or only moderately thick-
ened as revealed by PAS-stained histology (data not shown).
Some smaller cysts lined by an epithelial layer of isoprismatic
cells were filled with fluid of an increased density (Fig. 4a). As
revealed by scanning electron microscopy, epithelial micro-
polyps were occasionally seen protruding from the cysts wall
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Fig. 3. Autoradiograph of an RNAase
protection assay of EPO mRNA in the
kidneys of heterozygous Han:SPRD and
unaffected control rats. A total of 230 g of
total RNA was used for hybridization to the
EPO probe. Lane 1: size marker (HpaII digest
of pBR 322); lane 2: external standard
consisting of 5 g pooled RNA extracted from
severely hypoxic rats; lane 3 to 8: unaffected
control rats; lane 9 to 14: heterozygous Han:
SPRD rats.
Fig. 4. Light micrographs of 4-week-old homozygous Han:SPRD rats. (a) Cyst formation affects all segments of the nephron. Increased density
of the intracavitary fluid is present in some of the smaller cysts. Paraffin section, H&E, magnification (30x). (b) Tubular cystic expansion starts
directly with the beginning of the proximal tubule at the urinary pole; the glomerulus itself is unaffected. Semithin section, Richardson,
magnification (150 x).
(Fig. 5 a, b); in these cysts, the surrounding epithelium ap-
peared hyperplastic as well since densely arranged cell bodies
were bulging into the cyst lumen (Fig. 5a). In the homozygotes,
there was no evidence for a significant interstitial inflammation
and pericystic fibrosis.
In the heterozygotes, cystic tubular changes were little de-
veloped during the first four weeks of life (unpublished obser-
vation). At two months of age, significant cystic transformation
was encountered. Cysts were preferentially located in the inner
cortex and were less frequent in the outer cortex (Fig. 6a, 7a).
Only a few dilated tubules extended to the outer, but not to the
inner medulla (Fig. 6a). Inflammatory cells were focally present
in the pericystic interstitium.
Immunohistochemical analysis indicated that most of the
cystic changes were localized in the proximal tubule (Fig. 7
b-e). Immunostaining with antibodies to Tamm-Horsfall protein
(THP)—labeling the thick ascending limb of the loop of Henle
[32]—revealed that at this stage, only a minor proportion of
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Fig. 5. Scanning electron micro graphs lining tubular cysts from homozygous (a, b) and heterozygous Han:SPRD rats (c-f). (a) Epithelial
micropolyps of varying size are found along the wall of a proximal tubular cyst, Note protruding of adjacent epithelial cells. Magnification (400X).
(b) Higher resolution micrograph showing the polypoid cells from (a). Magnification (1500x). (C) An abrupt transition from intact to rarefied
proximal tubular brush border can be seen. Magnification (1500x). (d) Cyst derived from proximal tubular epithelium presenting polygonal luminal
cell borders and focal rarefication of brush border. Magnification (800x). (e) More advanced stages of proximal tubular cystic degeneration showing
further rarefication of brush border as well as zones where brush border is totally absent. Magnification (1500x). (f) Cystic epithelium resembling
the outer medullary collecting duct with few short microvilli and a prominent cilium. Magnification (800x).
dilated tubules or smaller cysts were derived from the distal proximale tubule [31], labeled approximately 75% of all cysts
tubule (Fig. 7b). Antibodies to neutral endopeptidase (NEP), (Fig. 7c). The remaining large NEP-unreactive cysts had either
which recognize the brush border of the straight part of the lost their brush border (Fig. 7 c-e) or were derived from the
A 2 months
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B 12 months
Fig. 6. Light micrographs of heterozygous Han:SPRD rats at the age of 2 months (A) and 12 months (B). While in (A), cysts are preferentially
located in the inner part of the renal cortex and numerous nephrons are still unaffected, in (B), number and size of cysts are greatly increased.
Paraffin sections, H&E. Both micrographs are at the same magnification (lOx).
proximal convoluted tubules. The proportion of cystically-
dilated cortical collecting ducts, which were morphologically
identified by their heterogenous cell composition, was even
smaller. These results were confirmed by scanning electron
microscopy revealing luminal surface heterogeneity in the cysts
(Fig. 5 c-f). The majority of cysts showed varying degrees of
proximal tubular brush border degradation, and transitions
from zones with intact brush border to areas where cells had a
polygonal outline and a rarefied brush border were frequently
observed (Fig. 5 c-e). Distal cysts were characterized by their
largely unchanged luminal epithelial aspect (Fig. 51). Conspi-
cously, initial stages of proximal tubular epithelial changes were
frequently encountered in undilated or only moderately dilated
proximal tubules. Here, epithelia of an otherwise normal epi-
thelial morphology revealed focal zones of less differentiated
epithelium characterized by a loss of brush border, prominent
widening of lateral intercellular spaces and an overall con-
densed appearance of the epithelium (Fig. 8). In these areas, the
number of cell nuclei per unit epithelial length was strikingly
higher than in the adjacent normal (albeit cystic) epithelium and
the underlying basement membrane was significantly thickened
as revealed by PAS staining. Mitotic figures observed both
within the epithelia and the underlying interstitial cells were
more frequent than in control tissue (data not shown).
Later stages (12 months of age) of renal cystic changes in the
heterozygotes were characterized by an overall increase in the
proportion and size of the cortical cysts, finally occupying the
entire cortex (Fig. 6b); in these stages, all tubular portions were
dilated or cystic, and a number of cysts were filled with a dense
fluid. Cyst-lining epithelia were simplified and flat, and had
mostly lost their tubulospecific characteristics. There was a
significant increase in interstitial fibrosis and number of inflam-
matory cells.
A sexual dimorphism of cyst development in the heterozy-
gotes has not been systematically studied, but was reported
elsewhere [27—29].
Ultrastructural morphology
Transmission electron microscopy of the initial stages of loss
of cystic epithelial differentiation in the proximal tubule of
2-month-old heterozygously affected animals indicated two
major changes (Fig. 8). First, the transition from normally
differentiated to less differentiated epithelial areas was abrupt
with typical proximal tubular cells juxtaposed to polygonal cells
with reduced basolateral interdigitations, widened intercellular
spaces and focal lack of brush border. Second, concomitant
with the transition from phenotypically normal to cystically less
differentiated epithelium, an abrupt increase in basement mem-
brane thickness was observed. The thickened basement mem-
branes either revealed a split and multilaminated aspect, or
were continuous with pericystic matrix accumulations contain-
ing electron dense grains, matrix vesicles and interwoven
bundles of striated collagen-type I fibers. Characteristically,
less differentiated cells resting on a structurally altered base-
ment membranes or larger subepithelial matrix accumulations
revealed a prominent increase in rough endoplasmic reticulum
and Golgi apparatus with numerous vesicles budding off the
cisternae, and an elevated number of free polyribosomes.
Similarly, fibroblasts underlying these areas of matrix deposits
revealed a highly developed rough endoplasmic reticulum and
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Fig. 7. Immunohistochemical determination
of cyst origin in kidneys of 2-month-old
heterozygous Han:SPRD rats. (a)
Morphological overview. Numerous cysts of
varying size are present in the inner cortex.
Semithin section, Richardson, magnification
(30X). (b) As revealed by anti-Tamm Horsfall
protein (THP) immunostaining, most of the
thick ascending limb segments are normal or
moderately dilated and only a few tubules are
cystically expanded. Paraffin section,
peroxidase-anti-peroxidase (PAP)
immunostaining, interference contrast optics,
magnification (30x). (c) Anti-neutral
endopeptidase (NEP) immunostaining for the
straight part of the proximal tubule. The
majority of cysts shows a positive
immunosignal (asterisk) indicating an origin
from the proximal straight tubule, whereas
other cysts, though morphologically derived
from the proximal tubule, are unreactive
(squares). Paraffin section, PAP
immunostaining, magnification (30x). (d)
Focal reduction of the NEP immunosignal is
due to rarefication of the proximal tubular
brush border as identified by interference
contrast optics (e). Arrowheads indicate the
transitions between normal-appearing and less
differentiated epithelium. Frozen section,
Texas red fluorescence (d) and interference
contrast optics (e), magnification (300x).
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Golgi apparatus indicating activated protein synthesis. In the
glomerulus, thickening of the parietal layer of Bowman's cap-
sule was occasionally observed, whereas the glomerular base-
ment membrane was not affected (Fig. 9b).
Histochemistry of extracellular matrix components
Areas of basement membrane thickening and interstitial
matrix accumulations were checked for the presence of type IV
collagen and laminin at the mRNA and protein level (Figs. 9 and
10). As revealed by 35S-labeled in situ hybridization, epithelia
with an underlying thickened basement membrane were
strongly expressing mRNA coding for the al-chain of type IV
collagen; al(IV) collagen mRNA-expression was significantly
increased, particularly in the focal areas of less differentiated
epithelia, whereas in neighboring intact-appearing epithelial
cells the autoradiographic signal was at background level (Fig.
lOa). In these areas of radioactively labeled epithelium the
underlying connective tissue was positive as well. Concomitant
in situ hybridization for laminin B! mRNA expression revealed
much weaker signals at these sites (Fig. lob). The areas labeled
by in situ hybridization were strongly immunopositive by
antibody staining for either matrix compounds in the estab-
lished phase of PKD indicating that the translation product was
accumulated in the subepithelial fibrotic zones (Fig. 10 c, d).
Here, a quantitative difference between type IV collagen and
laminin was not evident, since both showed an equally strong
(I s-....
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Fig. 8. Transmission electron micrographs of early cystic changes in 2-month-old heterozygous Han:SPRD rats. (a) Abrupt transition of
normal-appearing proximal tubular cells to less differentiated cystic epithelium. Note the loss of brush border and reduction of basolateral
interdigitations. The transition is paralleled by a sharp increase in basement membrane thickness. Magnification (4500x). (b) Proximal tubular
cystic alterations revealing pronounced widening of lateral intercellular spaces, reduction of basolateral interdigitations and focal rarefication of
brush border. Basement membrane is strongly thickened. Magnification (2000x).
labeling intensity in the pericystic interstitium and areas of man's capsule of the glomerulus, whereas the glomerular tuft
thickened basement membrane. Strong presence for al(IV) revealed an only moderate mRNA signal and no significant
collagen mRNA and immunoreactivity was also seen in Bow- immunostaining for type IV collagen (Fig. 9).
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Fig. 9. In situ hybridization and immunohistochemistry of collagen IV in glomeruli of 2-month-old heterozygous Han:SPRD rats. (a) In situ
hybridization using a 35S-labeled riboprobe shows strong al(IV) collagen mRNA expression over Bowman's capsule and underlying interstitial
cells, whereas the glomerulus is at background level. (b) Semithin section of a phenotypically altered renal corpuscle (stained with Richardson's
solution). Note the thickening of the glomerular capsule epithelia and the basement membrane (c, d). Immunohistochemical staining for collagen
IV and corresponding interference contrast morphology. Note the significant accumulation of collagen IV immunoreactive material at the
Bowman's capsule near the urinary pole. Analogous positions were selected in (a), (b) and (c, d). Autoradiographies were exposed for 15 days and
counterstained with H&E. All micrographs are at the same magnification (700x).
To reliably identify the cells involved in matrix proliferation,
non-radioactive in situ hybridization was performed with digox-
igenin-labeled riboprobes. In controls, labeling of single inter-
stitial fibroblasts was only occasionally observed (Fig. 1 la). In
the proximal tubular areas of initial loss of cystic differentiation,
however, both the cystic epithelial cells and the peritubular
fibroblasts that lie adjacent to areas of basement membrane
thickening contained striking amounts of al(IV) collagen
mRNA (Fig. lib). Fibroblasts could be identified by their
extensive cytoplasmic processes using interference contrast
optics. In more advanced stages of cystic degeneration, colla-
gen IV mRNA-expressing cells were more widely distributed
both in the cystic epithelia and underlying fibroblasts (Fig. 1 ic).
Jmmunohistochemistiy for Na,K-ATPase
To check for a presumed mislocation of tubular epithelial
Na,K-ATPase localization, immunohistochemistry with an an-
tibody against the al-subunit of Na,K-ATPase was performed
(Fig. 12). Labeling for Na,K-ATPase was low in the proximal
tubule and the collecting duct system, but the distal straight and
the distal convoluted tubule were strongly immunopositive
(Fig. 12c). Figure l2d shows that, compared to controls (Fig.
12c), a general weakening of the Na,K-ATPase immunolabeling
was encountered in cystically-altered distal tubules which were
identified by parallel immunostaining with antibodies to THP
(Fig. 12 a, b). An increase in cyst diameter appeared to
correlate with the reduction in Na,K-ATPase immunoreactivity
(Fig. 12 b, d). However, no reversal of the polarity of Na,K-
ATPase immunolabeling was found in renal cysts of various
stages, but in contrast, the weaker the staining, the more
basally it was localized (Fig. 12 e, 1).
Distribution of renin-containing cells
Both in homozygous and heterozygous animals, immunore-
active renin was detected predominantly in the juxtaglomerular
apparatus (JGA) at the vascular pole of the glomerulus. In all
specimens investigated, the number of immunoreactive cells
was variable ranging from only a few cells per JGA to several
cells extending upstream in the wall of the afferent glomerular
arteriole (Fig. l3d). Scattered immunoreactive cells were also
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Fig. 10. in situ hybridization and immunohistochemistry of extracellular matrix compounds in cysts of2-month-old heterozygous Han:SPRD rats.
in situ hybridization for al(IV) collagen (a) and laminin 81(b) using 35S-labeled riboprobes. (a) Strongly enhanced al(IV) collagen mRNA
expression is present over regions of condensed epithelium (arrowheads), whereas over adjacent, phenotypically normal epithelium, the signal is
at background level. Note that peritubular cells are labeled as well. (b) Laminin B! mRNA expression in a cystic region corresponding to (a); the
signal is only moderately increased over zones of epithelial condensations (arrowheads). (a, b) Frozen sections; autoradiographies were exposed
for 15 days and counterstained with H&E. (c-f) Immunohistochemical staining for collagen IV (c) and laminin (d). Morphology is identified by
interference contrast optics of the same sections (e, f). Massive accumulations of both collagen IV and laminin protein (arrows) are present
underneath regions of condensed epitheia and correspond to areas of thickened basement membrane. Paraffin sections, Texas red fluorescence
(c, d) and interference contrast optics (e, t). All micrographs are at the same magnification (300x).
found in the walls of arterioles without neighboring glomeruli
(Fig. 13e). The same distribution of renin-containing cells was
found at the mRNA level as revealed by radioactive as well as
non-isotopic in situ hybridization (Fig. 13 a-c). Differences
between the three genotypes (homozygotes, heterozygotes and
unaffected controls) were quantified as the percentage of gb-
meruli with an adherent positive juxtaglomerular staining indi-
cating the extent of granular renin storage (juxtagbomerular
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Fig. 11. Non-radioactive in situ hybridization of al(IV) collagen in 2-month-old heterozygous Han:SPRD rats. In situ hybridization using a
non-radioactive, digoxigenin UTP-labeled riboprobe for al(IV) collagen combined with interference contrast optics. (a) Normal cortical
parenchyma of an unaffected control kidney. A single al(IV) collagen expressing fibroblast is located in the peritubular interstitium. (b) Early stage
of proximal tubular cyst development in a 2-month-old heterozygous animal. Collagen IV mRNA is strongly expressed in regions of condensed
epithelium, whereas the adjacent epithelium is unlabeled. Note that peritubular fibroblasts (arrowheads) are labeled as well. (c) Small cyst
uniformly lined with a markedly altered prismatic epithelium. Collagen IV mRNA is strongly present in the epithelium and pericystic cells. The
latter are surrounded by solid accumulations of extracellular matrix. Frozen sections, interference contrast optics. All micrographs are at the same
magnification (550x).
index; Fig. 14). The amount of stored renin was significantly
decreased in 2-month-old heterozygotes (11.1 2.3%) com-
pared to age-matched controls (18.2 3.5%; P < 0.001), and
even more in 12-month-old heterozygotes (2.95 1.4% in the
diseased compared to 19.95 4.3% in the controls; P < 0.001).
In 4-week-old homozygously affected animals the juxtaglomer-
ular index was also at a low range (6.9 2.1%).
The number of renal arterioles containing immunoreactive
renin without neighboring glomeruli was also decreased in the
cystic animals. While no significant differences were detected
between heterozygous rats and the respective controls at the
age of two months (mean total number of positive arterioles per
section: 8.5 2.4 in the heterozygotes compared to 9 3.1 in
the controls), renin-containing cells in the walls of arterioles
were encountered neither in the homozygously affected rats nor
in the 12-month-old heterozygotes.
Renin mRNA signals as revealed by both radioactive and
non-isotopic in situ hybridization (Fig. 13 a-c) appeared to be
diminished similarly to the immunohistochemical signals and
therefore were not quantitatively evaluated.
Discussion
Comparison of homozygously and heterozygously affected
Han: SPRD rats reveals striking differences in the severity of
cystic disease. Homozygous animals manifest a rapidly pro-
gressive form of the disease and die of renal failure as early as
in the first month of extrauterine life, thus resembling the
recessive form of human PKD, whereas heterozygous animals
develop polycystic kidney disease in a manner similar to the
human form of autosomal dominant PKD with slowly progres-
sive cyst formation. Morphologically, homozygotes reveal mas-
sively enlarged kidneys with innumerable cysts already shortly
after birth, whereas in heterozygotes cysts develop focally in
the cortex extending into the medulla only occasionally. These
results confirm previous findings by other groups [27—291.
The severity of the disease in homozygotes is markedly more
pronounced than in heterozygotes, thereby indicating that
differences in cystic phenotype are determined by gene dose
[27—29]. Apart from the gene defect, epigenetic factors such as
hormones unique to the respective sexes may as well affect the
phenotypic expression of the disease, since male heterozygotes
manifest a significantly more severe form of the disease than
females [27—291.
Components of cyst formation include epithelial cell prolifer-
ation, basement membrane and intercellular matrix alterations
and ultimately, fluid secretion into the cyst lumen [6, 12, 43, 44].
These changes are thought to be underlaid by changes in tubular
epithelial polarity [15, 161 and growth factor expression [44, 45].
Increased cell proliferation is regarded as a central event in
PKD as renal tubules consisting of only a few cells in circum-
ference grow to finally reach an enormous size of several
millimeters in diameter with cyst walls containing large
amounts of cells [8]. This would mean that a cyst is not simply
a ballooning of a renal tubule and stretching of cells, formerly
thought to be due to an altered compliance of an abnormal
basement membrane, but indeed the result of increased cell
v t:
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Fig. 12. Immunofluorescence staining for Tamm-Horsfall protein (THP), a marker for the thick ascending limb (a, b), and Na,K-ATPase (c-f) in
2-month-old heterozygous Han:SPRD rats. Consecutive sections were used in (a, c) and (b, d). (a-d) Normal distal tubules exhibit a strong signal
both for THP (a) and Na,K-ATPase (c). Increases in distal tubular diameter are accompanied by reduction of Na,K-ATPase-immunoreactivity (d),
whereas the THP-immunosignal is unaffected (b). (e, I') High resolution of Na,K-ATPase immunostaining in an advanced stage of distal tubular cyst
formation (e) and corresponding interference contrast morphology on the same section (t). Immunostaining is partly reduced to the basal cell aspect
and partly absent. Arrowheads indicate the dimension of the cystic epithelium. Paraffin sections, Texas red fluorescence (a through e) and
interference contrast optics (t). Magnifications: a through d (180x); e, f (300x).
numbers [6—81. We have detected signs of epithelial cell hyper- reabsorptive vesicles and lysosomes indicated reduced cellular
plasia manifested by micropolyp formation within renal cysts of differentiation. In later stages of cyst formation, a uniformly
homozygous Han:SPRD rats, and by an increased number of simplified epithelium develops without any distinct morpholog-
mitoses, increased nuclear-to-cytoplasmic ratio and cell density ical features of its original nephron segment. The reason for the
in the initial stages of proximal tubular dilations in the heterozy- loss of epithelial differentiation in cystic epithelia is unclear.
gotes, where patch-like areas of less differentiated cells have Since in a number of tissues, differentiation and proliferation
been described previously [12, 29, 30]. In these areas, loss of appear to have a reciprocal relationship [46], these changes
brush border and basolateral interdigitations and reduction of could be caused by a genetically determined dysregulation of
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Fig. 13. In situ hybridization (a through c) and immunohistochemistry (d, e) for renin in polycystic kidneys of homozygous and heterozygous
Han:SPRD rats. (a) Hybridization with a 35S-labeled renin riboprobe showing renin mRNA along the afferent glomerular arteriole (arrowheads)
and at the juxtaglomerular apparatus. Renin mRNA is absent over the cystic epithelia; 4-week-old homozygous animal. (b) The same procedure
applied to the kidney of a 2-month-old heterozygous animals. Distribution of grains is similar to (a). (C) In situ hybridization using a non-radioactive
digoxigenin UTP-labeled renin riboprobe combined with interference contrast optics. Only vascular structures are labeled. Apart from the
localization at the juxtaglomerular apparatus, single renin mRNA containing cells are found further upstream in the wall of the afferent glomerular
arteriole. Two-month-old heterozygous animal. (d, e) Immunostaining for renin in the juxtaglomerular afferent arteriolar position of two
neighboring glomeruli (d) and showing exclusively vascular staining in an arteriolar wall adjacent to a late-stage tubular cyst (e; asterisk). No
tubular staining is present. Glomerulus (0). Frozen sections, (a, b) autoradiographies were exposed for 15 days and conterstained with H&E, (c)
interference contrast optics, (d, e) PAP, interference contrast optics. All micrographs are at the same magnification (450X).
cell proliferation. Possibly, consequent to epithelial cell prolif-
eration, cystic epithelia remain arrested in a less differentiated
state and the proportion of those epithelia increases with age so
that finally all nephron segments are involved.
Consistent with increased cell proliferation, changes in
growth factor expression and sensitivity have been described in
PKD [44, 45]. In vitro cyst formation was shown to be mediated
by epidermal growth factor (EGF) and transforming growth
factor (TGF)-a [10]. In contrast, TGF-j3, a potent inhibitor of
renal tubular proliferation and antagonist of the mitogenic
action of EGF, did not produce the expected inhibition in
cultured ADPKD cyst epithelium [44]. Moreover, transgenic
mice bearing the proto-oncogene c-myc [46, 47], the SV40
Large T antigen [48] and TGF-a [49] reproducibly developed
renal cysts and signs of epithelial hyperplasia. In situ hybrid-
ization studies have shown previously that in the cpk mouse—a
model for human ARPKD—as well as in the Han:SPRD rat,
c-myc overexpression was linked to cells engaged in cystogen-
esis [9, 29, 50]. In the cpk mouse, the proto-oncogenes c-los and
c-Ki-ras were also markedly raised [51]. A definitive causal role
of oncogenes for the development of renal cysts is, however,
not fully evident [6].
Cell proliferation in PKD may not necessarily be the primary
event in cystic tubular enlargement. Carone et al [52] found by
in vitro experiments that cyst-derived cells did not exhibit an
accelerated growth potential or possess any features of trans-
formed cells. Therefore, cellular expression of the PKD gene
may also depend on local factors from the microanatomical
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Age, months
Fig 14. Quantification of renin-positive cells (juxtaglomerular index).
Renin-positive juxtaglomerular apparatus (JGA) are given as the per-
centage of the total number of glomeruli. Values are means SD.
*significant difference. Two time points were evaluated (2- and 12-
month-old heterozygous Han:SPRD rats and their respective controls,
N = 6 per group).
environment that could modulate the phenotypic expression of
the defective gene [6, 52].
In Han:SPRD rats, extracellular matrix abnormalities were
quite striking in areas of initial epithelial transformation, where
focal plaques of less differentiated epithelium were resting on a
markedly thickened basement membrane [29, 30]. In these
zones, the transition from normal to thickened basement mem-
branes precisely coincided with the loss of structural character-
istics of the proximal tubular epithelium and with signs of cell
proliferation. The transition from intact to less differentiated
epithelium has been detected to occur in a "bottleneck" shape
with basement membrane thickening located focally at the
transition from normal-sized proximal tubule to the cystic
dilation [30]. Extracellular matrix abnormalities were charac-
terized by pericystic accumulations of collagen IV and laminin
and, as previously reported in Han:SPRD rats, by fibronectin
[29, 30]. These data were supported by in situ hybridization
histochemistry demonstrating that both epithelium and under-
lying fibroblasts, a cell type not usually associated with base-
ment membrane production, are involved in the overexpression
of matrix compounds. A much weaker, but still significant
collagen IV expression in both cystic epithelium and underlying
fibroblasts was also reported in cpk mice [13]. Initially it was
thought that basement membrane alterations might contribute
to cyst formation via a simple change in the distensibility of the
tubular basement membrane. However, Grantham et al [53]
could not demonstrate altered viscoelastic properties of the
pericystic basement membranes as compared to normal tubular
basement membranes.
It therefore appears more likely that compositional changes
of the extracellular matrix may contribute to cyst formation via
alterations in cell-matrix interactions [12]. Our study as well as
a previous report [29] indicate that the ultrastructure of cystic
tubular basement membrane is abnormal. Wilson, Hreniuk and
Gabow [54] have shown that human ADPKD cells in culture
produce greater amounts of extracellular matrix than did nor-
mal proximal and distal tubular epithelia. It is known that the
extracellular matrix can play a regulatory role in normal tissue
morphogenesis and may be involved in pathophysiological
changes [55, 56]. Cell culture studies have demonstrated that
with either normal or ADPKD cells, growth rates differed in
response to the matrix composition, thus illustrating the signif-
icance of this inductive interaction [54]. Collagen IV as the
major structural component of the basement membrane consti-
tutes a meshwork to which laminin and heparan sulfate proteo-
glycans bind [55, 57]. The functions of laminin involve its ability
to modulate cell behavior, which includes cell polarization,
adhesion and differentiation; proteoglycans are thought to reg-
ulate the permeability of the basement membrane [58]. A
defective synthesis and delayed processing of sulfated proteo-
glycans was seen in association with basement membrane
thickening [59].
The overexpression and accumulation of extracellular matrix
components during initial stages of cystogenesis could favor the
loss of epithelial differentiation as well by impeding the diffu-
sion of gas and solutes through fibrotic deposits between
epithelium and capillary bed. Regular epithelial function of the
cortical labyrinth, the major part of which is constituted by the
convoluted proximal tubule, relies almost completely on oxy-
gen metabolism [60]. A reduced diffusion to the tubular epithe-
hum may therefore contribute to changes in the epithelial
phenotype. In this respect, ischemic injury has been shown to
cause partial loss of differentiation of proximal tubule cells
resulting in changes of the apical brush border and loss of
epithelial polarization [61].
Epithelia derived from human cystic kidneys may reverse the
polarity of their cells with respect to localization of Na,K-
ATPase [15, 16]. In cystic epithelia, a shift of Na,K-ATPase
from a basolateral to an apical position is thought to be
promoting net fluid secretion into the cyst lumen to cause fluid
accumulation and subsequent cyst expansion [6, 44]. In the
Han:SPRD rat, however, no such phenomena were observed,
since the Na,K-ATPase-immunoreactive signal remained at the
basolateral side of the cyst-lining epithelium, and the immuno-
reactivity was only decreased in parallel with the degree of
cystic dilation.
Our study reveals that renal EPO production is impaired in
Han:SPRD rats. It is known that patients with ADPKD usually
suffer from less severe anemia than those with renal failure of
other etiologies, and their serum EPO values were reported to
be on average higher than those of other renal patients [2 1—231.
Nevertheless, the majority of these patients are anemic with
serum EPO concentrations being very variable, and in many
cases lower than in non-renal patients with a comparable
reduction of red cell mass.
The hematocrit as well as renal EPO mRNA levels in
Han:SPRD rats were significantly reduced, and serum EPO
concentrations were slightly lowered. Thus, the EPO response
to the reduction in red cell mass that occurs in normal kidneys
is clearly lacking in this polycystic rat model. This suggests that
the moderate anemia is in fact due to decreased EPO formation.
It must be considered however, that an expansion of the
extracellular fluid volume may have influenced the hematocrit.
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Table 2. Comparison between ADPKD in humans and PKD in homozygous and heterozygous Han:SPRD rats
Human ADPKD
Han:SPRD
Referenceshomozygous heterozygous
Inheritance autosomal dominant autosomal dominant 1, 2, 28
Gene locus chromosome 16 ? 5
Sexual dimorphism yes ND yes 28, 29, 64
Progredience slow rapid slow 4, 27—29
Degree of uremia + + + + + + 4, 27—29
Hypertension ++ ++ 18, 20, 32, 62
Renin content
Hematocrit
' , ,
ND
,
.
17—20, 62, 63
21
Serum EPO levels ND — 21, 23
Renal EPO mRNA ND 21
Affected nephron segments all all initial stage: PT
late stages: all
2, 8, 29, 30
Glomerular cysts yes no no 2, 8
Matrix alterations ++ + +++ 6, 12, 29, 30
Collagen IV t t t
Laminin t —' t
Fibronectin t ND t
Inflammation + — + 29, 30, 65
Na,K-ATPase 6, 15, 44
Localization apical ND basal
Activity t ND
Extrarenal manifestations yes no no 2, 27—29
Data include those of the present paper. Abbreviation ND is not determined.
However, the pericystic fibroblasts, which have recently been
identified as the site of EPO production in normal kidneys [241,
are strongly altered with respect to their microanatomical
environment. The extensive matrix accumulations around these
cells indicate a possible impairment of an oxygen-dependent
EPO formation [25, 60]. Whether the impairment of EPO
formation is comparatively moderate for the extent of renal
damage, as it is probably the case in human polycystic kidneys,
cannot be determined on the basis of the current data and would
require comparison with other models of non-cystic kidney
disease in rats.
Autosomal dominant PKD is often associated with hyperten-
sion, and the intrarenal renin-angiotensin-system has been
implicated in modulating the process of cyst formation [17—201.
Angiotensin II is known to act as a growth factor and to raise
blood pressure via an increase in vascular resistance and an
abnormal renal sodium handling [17—20]. Graham and Lindop
[18] observed a shift of immunoreactive renin in polycystic
kidneys from the juxtaglomerular position towards more prox-
imal portions of the afferent arteriolar wall as well as to cells
embedded in the pericystic connective tissue, and concluded
that the abnormal distribution of renin-containing cells could
affect both its intrarenal action and its access to circulation.
Tones et al [20] described the presence of immunoreactive
renin in the epithelium of cyst walls. In contrast, cystogenesis
in the Han:SPRD rat model apparently is not related to an
overactivated intrarenal renin system as renal renin levels,
expressed by the juxtaglomerular index of renin-containing
cells, indicated a significant reduction rather than an increase in
renal renin content. This reduction in renal renin levels may
also be due to expansion of the extracellular fluid volume. Both
homozygous and heterozygous Han:SPRD rats of different age
exhibited an abnormal arteriolar location of renin mRNA or
renin immunoreactivity in the vicinity of expanding cysts only
occasionally, probably caused by the compression of the vas-
culature. These findings were corroborated by others [62]
reporting that total renal renin mRNA was markedly decreased
in Han:SPRD rats. In contrast to a study in the Han:SPRD rat
by Keith et al [63], we could not detect any signs of tubular
epithelial renin immunoreactivity.
Plasma renin levels have been reported to be at normal range
in Han:SPRD rats [621. Accordingly, our study as well as a
previous report [27] did not reveal a significant increase in mean
systolic blood pressure in heterozygously affected animals up to
an age of 16 months. Thus, there is no compelling evidence for
a participation of angiotensin II in cystic growth in the Han:
SPRD rat.
In conclusion, our findings demonstrate that the Han:SPRD
rat is a suitable and well documented animal model for inherited
autosomal dominant PKD. Differences and similarities between
the rat model and human ADPKD are listed in Table 2. The
model is particularly suitable for the analysis of interactions
between tubular epithelia and extracellular matrix at the begin-
ning of cystic transformation.
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